翰宇药业：抗新冠鼻喷多肽项目HY3000将于近期提交IND申请

array(1) { [401330]=> array(2) { [2]=> array(3) { [0]=> string(12) "新冠疫情" [1]=> string(12) "翰宇药业" [2]=> string(9) "多肽药" } [4]=> array(1) { [0]=> string(19) "同花顺7x24快讯" } } }